Herrera GJC, Romero MKA, Pérez PR, Lizardi CJ

Language: Spanish
References: 17
Page: 23-27
PDF size: 103.22 Kb.

ABSTRACT

Idiopathic interstitial pneumonias represent a group of lung diseases of unknown etiology, characterized by diffuse parenchymal lung involvement with the potential to develop pulmonary fibrosis with the consequent affection in functional class. Typically, symptoms develop insidiously and in advanced cases, fibrosis is evident by the characteristic development of honeycombing. We present the case of a patient with community acquired pneumonia, without previous rheumatologic disease in whom the diagnosis of idiopathic pulmonary fibrosis was done. Finally, a brief review of the principal characteristics of the disease is showed.

REFERENCES

1. Mandell LA. Community-acquired pneumonia. Chest 1995; 108: 35s-42s.

2. Harrison´s et al. Principles of Internal Medicine: Pneumonia and Interstitial lung diseases: 16th edition, Mc-Graw-Hill Interamericana, EUA. pp 1528- 1560.

3. Habbermann et al. Mayo Clinic: Internal Medicine: Board review: 2004-2005. EUA; Lippincott Williams and Wilkins. pp 847-943.

4. Katzenstein AA, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157: 1301-15.

5. Askin FB. Back to the future: The Hamman-Rich syndrome and acute interstitial pneumonia. Mayo Clinic Proc 1990; 65: 1624-6.

6. Katzenstein ALA, Fiorelli RF. Nonspecific interstitial pneumonia/ fibrosis: histologic features and clinical significance. Am J Surg Pathol 1994; 18: 136-47.

7. King Jr TE, Costabel U, Cordier JF et al. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000; 161: 646-64.

8. Katzenstein ALA, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157: 1301-15.

9. Kondoh Y, Akira M et al. Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am J Respir Crit Care Med 2002; 165: 1551-6.

10. 10.Akira M. Computed tomography and pathologic findings in fulminant forms of idiopathic interstitial pneumonia. J Thor Imaging 1999; 14: 76-84.

11. 11.Bjoraker JA, Ryu JH, Edwin MK et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157(1): 199-203.

12. 12.Travis WD, King Jr TE, Bateman ED et al. American Thoracic Society/ European Respiratory Society International Multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.

13. 13.Katzenstein AL, Zisman DA, Litzky LA, Nguyen BT, Kotloff RM. Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol 2002; 26(12): 1567-77.

14. 14.Nagai S, Kitaichi M, Izumi T. Classification and recentadvances in idiopathic interstitial pneumonia. Curr Opin Pulm Med 1998; 4: 256-60.

15. 15.American Thoracic Society. ATS/ERS International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.

16. 16.Nagai S, Kitaichi M, Itoh H et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998; 12: 1010-9.

17. 17.Cottin V, Donsbeck AV, Revel D et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 164: 193-6.